Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 2,935.90
-11.00 (-0.37%)
Sep 11, 2026, 3:30 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 482.08 billion as of September 11, 2026. Its market cap has increased by 53.80% in one year.
Market Cap
482.08B
Enterprise Value
451.33B
Revenue
67.25B
Ranking
n/a
PE Ratio
42.71
Stock Price
2,935.90
ChartMarket Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 482.08B, an increase of 62.26%. That is a compound annual growth rate of 8.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 482.08B | 69.92% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.12T |
| Laurus Labs | 1.05T |
| Aurobindo Pharma | 973.54B |
| Mankind Pharma | 953.61B |
| Glenmark Pharmaceuticals | 698.31B |
| Alkem Laboratories | 619.47B |
| Ipca Laboratories | 499.09B |
| Ajanta Pharma | 447.18B |